« Previous
Next »
Tzu Chi Medical Journal
Volume 21, Issue 2
, Pages 103-109
, June 2009
Pathophysiology of Urothelial Dysfunction in Patients with Interstitial Cystitis/Painful Bladder Pain Syndrome: Increased Apoptosis and Decreased Junctional Protein Expression in the Urothelium due to Suburothelial Inflammation
References
- . Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases/Interstitial Cystitis Association scientific conference on interstitial cystitis . Urology . 2001;57(Suppl 6A):2–6
- . The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis . Urology . 2007;69(Suppl 4):34–40
- . Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis . BJU Int . 2000;85:995–999
- Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients . Am J Physiol Renal Physiol . 2008;295:F1613–F1623
- Differentiation potential of urothelium from patients with benign bladder dysfunction . BJU Int . 2007;99:1506–1516
-
.
The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis
.
Urology
. 2007;69(Suppl 4):9–16
- . Urine is necessary to provoke bladder inflammation in protamine sulfate induced urothelial injury . J Urol . 2008;180:1527–1531
-
.
The role of the bladder surface in interstitial cystitis/painful bladder syndrome
.
J Urol
. 2007;14:3599–3607
- Structure and function of suburothelial myofibroblasts in the human urinary bladder under normal and pathological conditions . Urologe A . 2007;46:1197–1202
- . Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders . Nat Clin Pract Urol . 2006;3:101–110
- Subcutaneous administration of botulinum toxin A reduces formalin-induced pain . Pain . 2004;107:125–133
- Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats . J Urol . 2002;168:2269–2274
- . Treatment of interstitial cystitis . Urology . 2004;63(Suppl 1):85–92
- . Cytologic examination of urine from patients with interstitial cystitis . Acta Cytol . 1998;42:923–927
- . Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis . J Urol . 2001;166:2121–2125
- . Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis . Am J Physiol Cell Physiol . 2006;290:C27–C34
- EGF and HB-EGF modulate inward potassium current in human bladder urothelial cells from normal and interstitial cystitis patients . Am J Physiol Cell Physiol . 2007;292:C106–C114
- . Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis . J Urol . 2005;174:2382–2387
- Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis . Urology . 2001;57(Suppl 1):9–14
- . Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis . J Urol . 2000;163:1440–1444
- . p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells . FEBS Lett . 2007;581:3795–3799
- . Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production . J Urol . 2000;164:2112–2118
- . Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis . Curr Urol Rep . 2006;7:440–446
- Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis . J Urol . 2004;171:1554–1558
- Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10 . Hum Genet . 1989;83:297–299
- . Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis . J Urol . 2008;179:764–769
- . Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis . Urology . 2007;69:17–23
- . Expression of intercellular adhesion molecules in the bladder of patients with interstitial cystitis . Urology . 2004;63:688–693
- . Effect of diagnostic hydrodistention and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis . Urology . 2002;60:46–51
- . Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients . World J Urol . 2007;25:407–413
- . Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis . Urology . 2003;61:1278–1284
- . Cell signaling in interstitial cystitis/painful bladder syndrome . Cell Signal . 2008;20:2174–2179
- . Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder . J Urol . 2004;172:2434–2439
- . Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder . Neuroreport . 1998;9:1455–1458
- . The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor . J Urol . 2001;165:975–979
- . Increased nerve growth factor expression triggers bladder overactivity . J Pain . 2004;5:150–156
- . Preliminary results of suburothelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis . Urol Int . 2005;75:170–174
- . Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study . Eur Urol . 2006;49:704–749
- . Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis . Urology . 2007;70:463–468
PII: S1016-3190(09)60020-3
doi: 10.1016/S1016-3190(09)60020-3
© 2009 Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Tzu Chi Medical Journal
Volume 21, Issue 2
, Pages 103-109
, June 2009
